Financials in USD. Standardized financial statements.
A compact view of how Medigene AG turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $6.03M | $31.25M | $10.46M | $8.00M | $10.51M | $7.58M | $7.68M | $4.10M | $3.10M | $12.58M |
| Revenue Growth? | -80.7% | +198.6% | +30.8% | -23.9% | +38.7% | -1.3% | +87.2% | +32.2% | -75.4% | 0.0% |
| Cost of Revenue? | $1.64M | $23.84M | $4.79M | $7.76M | $2.70M | $2.38M | $2.82M | $2.25M | $2.04M | $2.09M |
| Gross Profit? | $4.39M | $7.41M | $5.67M | $238,000 | $7.81M | $5.20M | $4.86M | $1.85M | $1.06M | $10.49M |
| Gross Margin? | +72.8% | +23.7% | +54.2% | +3.0% | +74.3% | +68.6% | +63.3% | +45.2% | +34.1% | +83.4% |
| Operating Expenses? | $20.54M | $16.53M | $16.19M | $27.44M | $28.09M | $27.87M | $21.94M | $20.72M | $15.20M | $14.97M |
| Operating Income? | -$16.15M | -$9.12M | -$10.51M | -$27.20M | -$20.28M | -$22.68M | -$17.09M | -$18.86M | -$14.15M | -$4.09M |
| EBITDA? | -$15.45M | $13.11M | -$6.51M | -$21.53M | -$17.10M | -$20.94M | -$15.70M | -$7.66M | -$11.90M | -$3.28M |
| Income Before Tax | -$16.59M | -$9.37M | -$10.28M | -$28.40M | -$19.92M | -$21.68M | -$12.94M | -$9.72M | -$14.21M | -$5.91M |
| Income Tax Expense | -$415,000 | -$1.04M | -$300,000 | $472,000 | $44,000 | -$454,000 | $634,000 | -$228,000 | -$400,000 | -$155,000 |
| Net Income? | -$16.18M | -$8.33M | -$9.98M | -$28.88M | -$19.96M | -$21.23M | -$13.57M | -$9.49M | -$13.00M | -$5.76M |
| EPS? | $-1.32 | $-0.64 | $-0.77 | $-2.23 | $-1.54 | $-0.85 | $-0.60 | $-0.45 | $-0.77 | $-0.47 |
| Diluted EPS? | $-1.32 | $-0.64 | $-0.77 | $-2.23 | $-1.54 | $-0.85 | $-0.60 | $-0.45 | $-0.77 | $-0.47 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality